Klöckner Pentaplast Reports Expansion

Published: April 17, 2018

MONTABAUR, GERMANY | According to Klöckner Pentaplast, the Pharmaceutical & Medical Device Films Division’s (kp Pharma) investment previously made in its Suzhou China facility is now fully operational. Company has expanded its converting capabilities for pharmaceutical business in China by installing a state-of-the-art slitting line at its Chinese site. This expansion reduces lead times and increases flexibility for all material grades supplied into the Chinese market through local storage and supply.

The slitting center in China meets the rigorous requirements of ISO 15378, and the closed clean room environment of the slitting area is in accordance with class D 100,000. Furthermore, the site has a fully operational micro-biological lab (environment class C 10,000) that enables quality control covering all requirements of the CFDA regulation.

Tracey Peacock, president, Pharmaceutical & Medical Device Films at kp, says, “We are seeing substantial growth in all product segments in Asia. New CFDA regulations in China are increasing the focus on the quality and performance of the packaging materials used, as well as increased demand for barrier performance to protect the sensitivity of new drugs. We are excited to make this first and significant step into China to support these trends in our marketplace.”

The new capacity will also support the Asian market as it continues to experience double-digit growth. Peacock adds, “We have been quietly adding to our capabilities in other parts of the world, and now we will accelerate the actions to address the growing Asian market place. Asia provides exciting opportunities for kp as regulation continues to increase with many EMEA and US standards being adopted. We are excited about the opportunities in the region, and this expansion, in conjunction with our local manufacturing in Thailand, is just the beginning of some great plans.”

This email address is being protected from spambots. You need JavaScript enabled to view it.